Menzella Francesco, Codeluppi Luca, Lusuardi Mirco, Galeone Carla, Valzania Franco, Facciolongo Nicola
Department of Medical Specialties, Pneumology Unit, Arcispedale Santa Maria Nuova, Azienda USL di Reggio Emilia- IRCCS, Via Amendola 2, 42122 Reggio Emilia, Italy.
Neuromotor & Rehabilitation Department, Neurology Unit, Arcispedale Santa Maria Nuova, Azienda USL di Reggio Emilia-IRCCS, Reggio Emilia, Italy.
Multidiscip Respir Med. 2018 Sep 1;13:32. doi: 10.1186/s40248-018-0145-4. eCollection 2018.
Acute respiratory failure can be triggered by several causes, either of pulmonary or extra-pulmonary origin. Pompe disease, or type II glycogen storage disease, is a serious and often fatal disorder, due to a pathological accumulation of glycogen caused by a defective activiy of acid α-glucosidase (acid maltase), a lysosomal enzyme involved in glycogen degradation. The prevalence of the disease is estimated between 1 in 40,000 to 1 in 300,000 subjects.
This case report describes a difficult diagnosis of late-onset Pompe disease (LOPD) in a 52 year old Caucasian woman with acute respiratory failure requiring orotracheal intubation and subsequent tracheostomy for long-term mechanical ventilation 24 h/day. Despite a complex diagnostic process including several blood tests, bronchoscopy with BAL, chest CT, brain NMR, electromyographies, only a muscle biopsy allowed to reach the correct diagnosis.
The most frequent presentation of myopathies, including LOPD, is proximal limb muscle weakness. Respiratory related symptoms (dyspnea on effort, reduced physical capacity, recurrent infections, etc.) and respiratory failure are often evident in the later stages of the diseases, but they have been rarely described as the onset symptoms in LOPD. In our case, a third stage LOPD, the cooperation between pulmonologists and neurologists was crucial in reaching a correct diagnosis despite a very complex clinical scenario due to different confounding co-morbidities as potential causes of respiratory failure and an atypical presentation. In this patient, enzyme replacement therapy with infusion of alglucosidase alfa was associated with progressive reduction of ventilatory support to night hours, and recovery of autonomous walking.
急性呼吸衰竭可由多种原因引发,这些原因既可以是肺部的,也可以是肺外的。庞贝病,即II型糖原贮积病,是一种严重且常致命的疾病,由于酸性α-葡萄糖苷酶(酸性麦芽糖酶)活性缺陷导致糖原病理性蓄积,酸性α-葡萄糖苷酶是一种参与糖原降解的溶酶体酶。该病的患病率估计在每40000至300000人中出现1例。
本病例报告描述了一名52岁白种女性迟发性庞贝病(LOPD)的疑难诊断过程,该患者因急性呼吸衰竭需要经口气管插管,随后进行气管切开以接受每天24小时的长期机械通气。尽管诊断过程复杂,包括多项血液检查、支气管镜检查及支气管肺泡灌洗、胸部CT、脑部核磁共振成像、肌电图检查,但只有肌肉活检才得以做出正确诊断。
包括LOPD在内的肌病最常见的表现是近端肢体肌肉无力。与呼吸相关的症状(劳力性呼吸困难、体能下降、反复感染等)及呼吸衰竭在疾病后期往往很明显,但在LOPD中很少被描述为起病症状。在我们的病例中,患者处于LOPD第三阶段,尽管由于不同的混杂合并症作为呼吸衰竭的潜在原因以及非典型表现导致临床情况非常复杂,但呼吸科医生和神经科医生的合作对于做出正确诊断至关重要。在该患者中,静脉输注阿糖苷酶α进行酶替代治疗与通气支持逐渐减少至夜间使用以及自主行走能力恢复相关。